181 related articles for article (PubMed ID: 23433403)
1. Dose-dependent effects of short term atorvastatin treatment on arterial wall properties and on indices of left ventricular remodeling in ischemic heart failure.
Tousoulis D; Oikonomou E; Siasos G; Chrysohoou C; Zaromitidou M; Kioufis S; Maniatis K; Dilaveris P; Miliou A; Michalea S; Papavassiliou AG; Stefanadis C
Atherosclerosis; 2013 Apr; 227(2):367-72. PubMed ID: 23433403
[TBL] [Abstract][Full Text] [Related]
2. Atorvastatin treatment improves endothelial function through endothelial progenitor cells mobilization in ischemic heart failure patients.
Oikonomou E; Siasos G; Zaromitidou M; Hatzis G; Mourouzis K; Chrysohoou C; Zisimos K; Mazaris S; Tourikis P; Athanasiou D; Stefanadis C; Papavassiliou AG; Tousoulis D
Atherosclerosis; 2015 Feb; 238(2):159-64. PubMed ID: 25525743
[TBL] [Abstract][Full Text] [Related]
3. Atorvastatin improves endothelial function and cardiac performance in patients with dilated cardiomyopathy: the role of inflammation.
Liu M; Wang F; Wang Y; Jin R
Cardiovasc Drugs Ther; 2009 Oct; 23(5):369-76. PubMed ID: 19636689
[TBL] [Abstract][Full Text] [Related]
4. Neutral effect on markers of heart failure, inflammation, endothelial activation and function, and vagal tone after high-dose HMG-CoA reductase inhibition in non-diabetic patients with non-ischemic cardiomyopathy and average low-density lipoprotein level.
Bleske BE; Nicklas JM; Bard RL; Brook RD; Gurbel PA; Bliden KP; Rajagopalan S; Pitt B
J Am Coll Cardiol; 2006 Jan; 47(2):338-41. PubMed ID: 16412857
[TBL] [Abstract][Full Text] [Related]
5. Long-term statin therapy in patients with systolic heart failure and normal cholesterol: effects on elevated serum markers of collagen turnover, inflammation, and B-type natriuretic peptide.
Abulhul E; McDonald K; Martos R; Phelan D; Spiers JP; Hennessy M; Baugh J; Watson C; O'Loughlin C; Ledwidge M
Clin Ther; 2012 Jan; 34(1):91-100. PubMed ID: 22154198
[TBL] [Abstract][Full Text] [Related]
6. Statin therapy improves brachial artery vasodilator function in patients with Type 1 diabetes and microalbuminuria.
Dogra GK; Watts GF; Chan DC; Stanton K
Diabet Med; 2005 Mar; 22(3):239-42. PubMed ID: 15717868
[TBL] [Abstract][Full Text] [Related]
7. Pleiotropic effects of atorvastatin in heart failure: role in oxidative stress, inflammation, endothelial function, and exercise capacity.
Castro PF; Miranda R; Verdejo HE; Greig D; Gabrielli LA; Alcaino H; Chiong M; Bustos C; Garcia L; Mellado R; Vukasovic JL; Godoy I; Lavandero S
J Heart Lung Transplant; 2008 Apr; 27(4):435-41. PubMed ID: 18374881
[TBL] [Abstract][Full Text] [Related]
8. Long-term effect of atorvastatin on neurohumoral activation and cardiac function in patients with chronic heart failure: a prospective randomized controlled study.
Yamada T; Node K; Mine T; Morita T; Kioka H; Tsukamoto Y; Tamaki S; Masuda M; Okuda K; Fukunami M
Am Heart J; 2007 Jun; 153(6):1055.e1-8. PubMed ID: 17540209
[TBL] [Abstract][Full Text] [Related]
9. Short-term effect of atorvastatin on endothelial function in healthy offspring of parents with type 2 diabetes mellitus.
Amudha K; Choy AM; Mustafa MR; Lang CC
Cardiovasc Ther; 2008; 26(4):253-61. PubMed ID: 19035876
[TBL] [Abstract][Full Text] [Related]
10. The effects of atorvastatin on endothelial function in diabetic patients and subjects at risk for type 2 diabetes.
Economides PA; Caselli A; Tiani E; Khaodhiar L; Horton ES; Veves A
J Clin Endocrinol Metab; 2004 Feb; 89(2):740-7. PubMed ID: 14764790
[TBL] [Abstract][Full Text] [Related]
11. A randomized trial of the effect of statin and fibrate therapy on arterial function in CKD.
Dogra G; Irish A; Chan D; Watts G
Am J Kidney Dis; 2007 Jun; 49(6):776-85. PubMed ID: 17533020
[TBL] [Abstract][Full Text] [Related]
12. Early effects on endothelial function of atorvastatin 40 mg twice daily and its withdrawal.
Taneva E; Borucki K; Wiens L; Makarova R; Schmidt-Lucke C; Luley C; Westphal S
Am J Cardiol; 2006 Apr; 97(7):1002-6. PubMed ID: 16563905
[TBL] [Abstract][Full Text] [Related]
13. Effects of low-dose atorvastatin on arterial stiffness and central aortic pressure augmentation in patients with hypertension and hypercholesterolemia.
Kanaki AI; Sarafidis PA; Georgianos PI; Kanavos K; Tziolas IM; Zebekakis PE; Lasaridis AN
Am J Hypertens; 2013 May; 26(5):608-16. PubMed ID: 23449607
[TBL] [Abstract][Full Text] [Related]
14. Effects of atorvastatin on arterial endothelial function in coronary bypass surgery.
Chello M; Goffredo C; Patti G; Candura D; Melfi R; Mastrobuoni S; Di Sciascio G; Covino E
Eur J Cardiothorac Surg; 2005 Dec; 28(6):805-10. PubMed ID: 16274999
[TBL] [Abstract][Full Text] [Related]
15. Effect of atorvastatin on non-ischemic heart failure and matrix metalloproteinase-2 and 9 in rats.
Cheng G; Xu G; Cai HW; Wang HH; Bao XF
Acta Pharmacol Sin; 2007 Apr; 28(4):511-7. PubMed ID: 17376290
[TBL] [Abstract][Full Text] [Related]
16. Protective effect of atorvastatin on acute systemic inflammation-induced endothelial dysfunction in hypercholesterolaemic subjects.
Vlachopoulos C; Aznaouridis K; Dagre A; Vasiliadou C; Masoura C; Stefanadi E; Skoumas J; Pitsavos C; Stefanadis C
Eur Heart J; 2007 Sep; 28(17):2102-9. PubMed ID: 17597050
[TBL] [Abstract][Full Text] [Related]
17. Effects of atorvastatin on arterial stiffness in chronic kidney disease: a randomised controlled trial.
Fassett RG; Robertson IK; Ball MJ; Geraghty DP; Sharman JE; Coombes JS
J Atheroscler Thromb; 2010 Mar; 17(3):235-41. PubMed ID: 20032570
[TBL] [Abstract][Full Text] [Related]
18. Effect of atorvastatin on peripheral endothelial function and systemic inflammatory markers in patients with stable coronary artery disease.
Alber HF; Frick M; Süssenbacher A; Dörler J; Dichtl W; Stocker EM; Pachinger O; Weidinger F
Wien Med Wochenschr; 2007 Feb; 157(3-4):73-8. PubMed ID: 17340064
[TBL] [Abstract][Full Text] [Related]
19. Effect of atorvastatin therapy and conversion to tacrolimus on hypercholesterolemia and endothelial dysfunction after renal transplantation.
Wissing KM; Unger P; Ghisdal L; Broeders N; Berkenboom G; Carpentier Y; Abramowicz D
Transplantation; 2006 Sep; 82(6):771-8. PubMed ID: 17006324
[TBL] [Abstract][Full Text] [Related]
20. Protection from procedural myocardial injury by atorvastatin is associated with lower levels of adhesion molecules after percutaneous coronary intervention: results from the ARMYDA-CAMs (Atorvastatin for Reduction of MYocardial Damage during Angioplasty-Cell Adhesion Molecules) substudy.
Patti G; Chello M; Pasceri V; Colonna D; Nusca A; Miglionico M; D'Ambrosio A; Covino E; Di Sciascio G
J Am Coll Cardiol; 2006 Oct; 48(8):1560-6. PubMed ID: 17045888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
